He learned how insurers deny claims from the inside. Then he built the machine that fights back for the doctors.
There is a kind of problem most founders drive right past. It has no glamour, no launch-day confetti, no viral demo. In American healthcare, that problem has a dull, bureaucratic name - revenue cycle management - and it quietly swallows a fortune every year: the money hospitals and clinics are owed but never quite manage to collect. Akash Magoon looked at that mess and did the strange thing. He slowed down.
Magoon is the co-founder and chief executive of Adonis, a New York company that uses artificial intelligence to help medical providers get paid - faster, more completely, and with fewer humans buried in paperwork. He runs it with his brother, Aman, who serves as chief product officer. In roughly four years the two have raised close to $94 million, grown revenue fourfold in a single year, and turned a subject most people find impossibly boring into one of the fastest-growing healthtech stories in the country.
What makes the story worth telling is not the funding. It is where the idea came from.
Before Adonis, the Magoon brothers built a benefits platform - a kind of TurboTax for choosing health insurance during open enrollment. It was there, working shoulder to shoulder with insurers, that they picked up something valuable and almost accidental: a working knowledge of how claims actually get evaluated, and how often they get denied. They saw the machinery from the payer's side of the table.
Most people would have filed that away. The brothers flipped it. If they understood exactly how insurers say no, they reasoned, they could build something for the people constantly on the receiving end of that no - the doctors, the clinics, the hospital billing departments drowning in rejected claims.
"We knew that in the medical provider ecosystem, there needed to be a new company that was taking a renewed approach to how everyone was thinking about this space."Akash Magoon
That is the quiet engine underneath Adonis. Not a clever algorithm dreamed up in a vacuum, but a hard-won read of an opaque system, pointed in the opposite direction. It is the sort of advantage you cannot buy or Google. You have to have lived inside the problem.
Magoon nearly ended up in medicine himself. In high school he volunteered at a Baltimore hospital, testing the idea that he might one day wear the white coat. The day-to-day, it turned out, did not inspire him. But something about the system around it did. At the University of Maryland, studying computer science, he found the seam he would spend his career working: the place where software meets healthcare.
"You can use software and technology to empower the U.S. health care system to be more effective."Akash Magoon
He credits the instinct to his family. His parents emigrated from India in the late 1970s and ran a string of small businesses - the kind of upbringing where you absorb how a business actually breathes long before anyone teaches you the word "revenue." In that house, medicine was spoken of as the highest calling. Magoon found a way to serve it without ever picking up a stethoscope.
"I have always had an innate curiosity to find a better way of doing something."Akash Magoon
Adonis was not his first company, and that matters. After graduating from Maryland in 2018, Magoon strung together a fast, unglamorous engineering education - stints tied to Amazon Web Services, Bloomberg, the payments startup Cedar, and Enigma Technologies. Then, in 2019, he co-founded Nayya, an AI platform for insurance benefits, where he served as chief technology officer and board member. Nayya grew into a company valued at roughly $515 million.
Most people would have settled in and enjoyed the ride. Magoon left to start over. In 2022 he launched Adonis with his brother, trading a proven, valuable business for a harder, less obvious one - because the second problem, the money maze on the provider side, was the one he could not stop thinking about.
Every good origin story has a spark, and Magoon's is almost too on-the-nose. An injury on a New York City basketball court sent him into the American medical system as a patient. What he found on the other side was not the injury - it was the aftermath: the billing statements, the confusion, the layers of inefficiency between getting care and settling up for it. He came out the far side with a conviction that revenue cycle management was one of the biggest, least examined failures in modern medicine.
He turned that irritation into a company. The frustration a lot of us feel and forget, he chose to keep feeling until it became a product.
The product Magoon is building points at a specific, almost radical end state. Today, armies of people at hospitals chase claims one by one - resubmitting, appealing, calling insurers, hunting down the reasons a payment stalled. Adonis wants to hand nearly all of that to software. In 2025 the company launched agentic AI - systems that don't just flag a problem but act on it - and reports resolving around 90% of billing issues autonomously.
Magoon's north star is a phrase he keeps returning to: an "exceptions-driven revenue cycle." In his five-to-seven-year vision, maybe one claim in a hundred is unusual enough to need a human. The other ninety-nine flow through untouched. It is a big claim, and he ties it to something bigger than efficiency.
"Minimize friction around revenue so hospitals can reinvest those proceeds back into improving patient care."Akash Magoon
That is the argument he makes for why any of this matters. Money recovered from a broken billing process is not abstract. It is nurses, equipment, beds - the parts of medicine patients actually see. Fix the plumbing, and the whole house works better.
For a CEO whose company grew revenue fourfold in a year, Magoon stays unusually close to the ground. He is described as deeply hands-on, still getting on calls with customers and his own teams, leading with a mix of accessibility and humility. Adonis's growth story bears the fingerprints of that involvement: the company shifted from relying on referrals and word of mouth to a deliberate inbound engine of content and events, and grabbed an estimated 5% market share inside its first year.
There is a cultural bet in there, too. In an era of fully remote startups, Magoon built an intentional in-person culture in New York, near the World Trade Center. He wanted the friction of proximity - the fast hallway conversation, the whiteboard nobody scheduled - as a feature, not a cost.
Magoon has collected the recognition that tends to follow this kind of trajectory - a spot on the CB Insights Digital Health 50, a place on DHNY's DH100, a Top 25 Founder of 2025 nod. He also keeps a thread running back to where it started, mentoring University of Maryland students and funding a scholarship at his alma mater.
But the interesting thing about Magoon is not the plaques. It is his taste in problems. He picked the unsexy one on purpose. He walked away from a valuable company to chase it. He built a rare, insider understanding of a closed system and aimed it at the people getting squeezed. And he has been remarkably consistent about what he is trying to do - not sell more software, but shrink the distance between a doctor doing the work and a doctor getting paid for it, until the paperwork nearly disappears.
If he pulls it off, most of the people whose claims flow cleanly through Adonis will never hear his name. That, more or less, is the point. The best infrastructure is the kind you stop noticing. Magoon is betting his career that medicine's money maze can become exactly that quiet.